{
  "generated": "2025-10-23T09:24:46.047570+00:00",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "source_evidence": "entries/safety/nsaid-protocol-ren-nsaid-mit/renal_safety/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "REN-NSAID-MIT_01",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_risk_mitigation",
      "population": "Adults with renal risk mitigation concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/ren-nsaid-mit-01",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-01",
      "citation": "REN-NSAID-MIT_01 (2015); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal risk mitigation concerns; Outcome: renal_risk_mitigation; DOI: 10.1234/ren-nsaid-mit-01; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "REN-NSAID-MIT_02",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_risk_mitigation",
      "population": "Adults with renal risk mitigation concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/ren-nsaid-mit-02",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-02",
      "citation": "REN-NSAID-MIT_02 (2016); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal risk mitigation concerns; Outcome: renal_risk_mitigation; DOI: 10.1234/ren-nsaid-mit-02; Adverse Events: Transient headache."
    },
    {
      "study_id": "REN-NSAID-MIT_03",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_risk_mitigation",
      "population": "Adults with renal risk mitigation concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/ren-nsaid-mit-03",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-03",
      "citation": "REN-NSAID-MIT_03 (2017); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal risk mitigation concerns; Outcome: renal_risk_mitigation; DOI: 10.1234/ren-nsaid-mit-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/ren-nsaid-mit-01",
      "study_ids": [
        "REN-NSAID-MIT_01"
      ],
      "primary_study_id": "REN-NSAID-MIT_01",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ren-nsaid-mit-02",
      "study_ids": [
        "REN-NSAID-MIT_02"
      ],
      "primary_study_id": "REN-NSAID-MIT_02",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ren-nsaid-mit-03",
      "study_ids": [
        "REN-NSAID-MIT_03"
      ],
      "primary_study_id": "REN-NSAID-MIT_03",
      "url": "https://doi.org/10.1234/ren-nsaid-mit-03"
    }
  ],
  "manifest_hash": "sha256:5ad3ffa3ada588a795244c9680eae6d990223a2148d15f40c725371682057c97"
}
